Des Walsh, PhD
Imperial College London
Director of Research Strategy for the Faculty of Medicine
Board member: 2017-
Judith Frydman, PhD
Stanford
Donald Kennedy Chair in School or Humanities and Sciences and Professor of Genetics
Board member: 2021-
Michael Heneka, MD
LCSB
Director of the Luxembourg Centre for Systems Biomedicine
Board member: 2017-
Alan Koretsky, PhD
NIH
Senior Investigator, Laboratory of Functional and Molecular Imaging
Board member: 2017-
Stéphanie Lacour, PhD
EPFL
Foundation Bertarelli Chair in Neuroprosthetic Technology
Board member: 2021-
Guy Rouleau, OQ, MD, PhD, FRCPC, FRSC
The Neuro
Director of The Neuro (Montreal Neurological Institute and Hospital)
Board member: 2017-
Erin Schuman, PhD
Max Planck Institute
Professor and Director, Department of Synaptic Plasticity at the Max Planck Institute for Brain Research
Board Member: 2021-
Maria-Elena Torres-Padilla, PhD
Institute of Epigenetics and Stem Cells
Director, Institute of Epigenetics and Stem Cells, Helmholtz Zentrum München
Board member: 2021-
Dominic Walsh, BSc, PGCE, PhD
Biogen
VP, Alzheimer's Disease and Dementia Research Unit at Biogen
Board member: 2021-
How temperature and circadian rhythms intersect to regulate a protein shown to protect against neurodegeneration
A new study led by Dr Marco Brancaccio (UK DRI at Imperial) and Dr Marieke Hoekstra (former UK DRI at Imperial, now VIB-KU Leuven Center for Brain & Disease Research) offers a deeper insight into how a neuroprotective pathway is regulated both by temperature and the body clock. This research, published in the journal PNAS, could open up new therapeutic avenues for neurodegenerative disease. Read more on the UK DRI website
Introducing Cynthia Sandor: Pioneering earlier detection of Parkinson’s
Dr Cynthia Sandor, former Emerging Leader at the UK DRI at Cardiff, joins the UK DRI at Imperial as a Group Leader, where she will be tackling early diagnosis of Parkinson’s.
With a background in genetics, Dr Sandor uses computational methods to bring greater understanding to the underlying molecular mechanisms of Parkinson’s. Read more about Cynthia's work on the UK DRI website.
